MARÍA JOSÉ
SÁNCHEZ PÉREZ
DOCENTE INVITADA
Hospital Universitario de Donostia
San Sebastián, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario de Donostia (16)
2022
-
Follow-up care of 12 months of patients with bladder cancer in Spain: A multicenter prospective cohort study
Medicine (United States), Vol. 101, Núm. 42, pp. E31175
2021
-
Follow-up care over 12months of patients with prostate cancer in Spain A multicenter prospective cohort study
Medicine (United States), Vol. 100, Núm. 47
2019
-
Rapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVR
Scientific Reports, Vol. 9, Núm. 1
2017
-
Clinical interval and diagnostic characteristics in a cohort of bladder cancer patients in Spain: a multicenter observational study
BMC research notes, Vol. 10, Núm. 1, pp. 708
2016
-
No association between fish consumption and risk of stroke in the Spanish cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-Spain): A 13·8-year follow-up study
Public Health Nutrition, Vol. 19, Núm. 4, pp. 674-681
-
Unprocessed red meat and processed meat consumption and risk of stroke in the Spanish cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC)
European Journal of Clinical Nutrition, Vol. 70, Núm. 3, pp. 313-319
2015
-
Association between different obesity measures and the risk of stroke in the EPIC Spanish cohort
European Journal of Nutrition, Vol. 54, Núm. 3, pp. 365-375
-
Clinical intervals and diagnostic characteristics in a cohort of prostate cancer patients in Spain: A multicentre observational study
BMC Urology, Vol. 15, Núm. 1
-
Comparison of the prognostic value of liver biopsy and FIB-4 index in patients coinfected with HIV and hepatitis C virus
Clinical Infectious Diseases, Vol. 60, Núm. 6, pp. 950-958
-
Dual treatment with lopinavir-ritonavir plus lamivudine versus triple treatment with lopinavir-ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): A randomised, open-label, non-inferiority trial
The Lancet Infectious Diseases, Vol. 15, Núm. 7, pp. 785-792
-
Quality of life in patients with non-muscle-invasive bladder cancer: One-year results of a multicentre prospective cohort study
Urologic Oncology: Seminars and Original Investigations, Vol. 33, Núm. 1, pp. 19.e7-19.e15
2014
-
Alcohol consumption and survival after a breast cancer diagnosis: A literature-based meta-analysis and collaborative analysis of data for 29,239 cases
Cancer Epidemiology Biomarkers and Prevention, Vol. 23, Núm. 6, pp. 934-945
-
Bladder cancer index: Cross-cultural adaptation into Spanish and psychometric evaluation
Health and Quality of Life Outcomes, Vol. 12, Núm. 1
-
Effects of sustained viral response in patients with HIV and chronic hepatitis C and nonadvanced liver fibrosis
Journal of Acquired Immune Deficiency Syndromes, Vol. 66, Núm. 3, pp. 280-287
2011
-
Effect of accompanying antiretroviral drugs on virological response to pegylated interferon and ribavirin in patients co-infected with HIV and hepatitis C virus
Journal of Antimicrobial Chemotherapy, Vol. 66, Núm. 12, pp. 2843-2849
-
Post hoc analysis of pregabalin vs. non-pregabalin treatment in patients with cancer-related neuropathic pain: Better pain relief, sleep and physical health
Clinical and Translational Oncology, Vol. 13, Núm. 9, pp. 656-663